Joinn Laboratories(China)Co.,Ltd. Joinn Laboratories(China)Co.,Ltd.

Joinn Laboratories(China)Co.,Ltd.

603127

주식 순위 #3810
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
주가
$6.82
시가총액
$4.30B
변동 (1일)
-6.30%
변동 (1년)
48.79%
국가
CN
거래 Joinn Laboratories(China)Co.,Ltd. (603127)

카테고리

Healthcare
Joinn Laboratories(China)Co.,Ltd. (603127)의 배당 이력
Joinn Laboratories(China)Co.,Ltd. (주식 심볼: 603127)은 총 9회의 배당금을 지급했습니다.
모든 배당금의 합계 (주식 분할 반영): $1.28
배당 수익률 (TTM): 0.0026
Joinn Laboratories(China)Co.,Ltd. (603127)의 2018부터 2026까지 배당 지급 내역
연간 배당 지급
연도 배당금 (주식 분할 조정됨) 변화
2026 (TTM) $0.12 300.00%
2025 $0.03 -81.25%
2024 $0.16 -60.00%
2023 $0.4 55.58%
2022 $0.2571 101.49%
2021 $0.1276 44.18%
2020 $0.0885 58.60%
2019 $0.0558 40.20%
2018 $0.0398 0.00%
모든 배당 지급 목록
연도 배당금 변화
2026 (TTM) $0.12 300.00%
2025 $0.03 -81.25%
2024 $0.16 -71.43%
2023 $0.56 11.11%
2022 $0.504 44.00%
2021 $0.35 2.94%
2020 $0.34 13.33%
2019 $0.3 0.00%
2018 $0.3 0.00%
유사 기업 또는 경쟁사의 배당 지급